Press release
Colchicine Market worth $2.49 billion by 2030, growing at a CAGR of 7.85% - Exclusive Report by 360iResearch
Colchicine Market | 360iResearch
The Global Colchicine Market to grow from USD 1.46 billion in 2023 to USD 2.49 billion by 2030, at a CAGR of 7.85%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/colchicine?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Colchicine is a medication derived from the plant Colchicum autumnale, commonly known as autumn crocus. It holds a significant place in medical treatment for its efficacy in addressing gout attacks and pericarditis. The expanding use of colchicine is primarily fueled by its potential to manage and reduce the inflammation associated with these conditions effectively, thereby improving patients' quality of life. Furthermore, its application is broadening in cardiovascular disease management, showcasing potential beyond traditional uses. Despite its benefits, colchicine's use is hindered by its narrow therapeutic index, leading to potential toxicity if not dosed properly. This restraint can be mitigated through adherence to strict dosing guidelines and monitoring by healthcare professionals to ensure safety and efficacy. Ongoing research exploring its anti-inflammatory mechanisms may introduce new therapeutic indications, expanding its applicability in the healthcare sector.
In the Americas, particularly in the United States, colchicine's use is strictly regulated with patents and FDA approval governing its prescription, a scenario that underscores the region's focus on quality and compliance. The major pharmaceutical companies in North America engage in continuous research and development, leading to an advanced but expensive healthcare framework. The APAC region, with countries such as India and China, is pivotal in the production of Colchicine, which is attributed to their large-scale generic pharmaceutical manufacturing capabilities. These countries focus on cost-effective production while striving to meet global standards, playing a crucial role in supplying affordable Colchicine to markets worldwide. The EMEA region showcases a diverse approach due to varying regulatory environments across countries. European nations maintain strict regulatory standards similar to those of the Americas, emphasizing safety and efficacy, coupled with a strong generic market presence. The Middle East and African markets are increasingly recognizing the importance of Colchicine, albeit facing challenges related to access and affordability, influenced by economic disparities.
Market Segmentation & Coverage:
This research report categorizes the Colchicine Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Dosage Formulation, market is studied across Liquid, Semisolid Gel, and Solid. The Solid is projected to witness significant market share during forecast period.
Based on Age, market is studied across Adult, Children, and Senior. The Children is projected to witness significant market share during forecast period.
Based on Route of Administration, market is studied across Oral and Topical. The Topical is projected to witness significant market share during forecast period.
Based on Sales Channels, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Retail Pharmacies is projected to witness significant market share during forecast period.
Based on Application, market is studied across Actinic Keratosis, Behcet's Disease, Dermatitis Herpetiformis, Familial Mediterranean Fever, Gout, and Paget's Disease. The Actinic Keratosis is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 40.35% in 2023, followed by Europe, Middle East & Africa.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/colchicine?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Colchicine Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Colchicine Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Colchicine Market, highlighting leading vendors and their innovative profiles. These include AGEPHA Pharma USA, LLC, Alchem International Pvt Ltd, Ascend Laboratories, LLC, Aurobindo Pharma Limited, Bio-Techne Corporation, bioWORLD by GeneLinx International, Inc., Camber Pharmaceuticals, Inc., Dr. Reddy's Laboratories Ltd., Endo International PLC, EURO-PHARM International Canada Inc., Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., Hikma Pharmaceuticals, Indena S.p.A., LGM Pharma, Odan Laboratories Ltd, Pfizer Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Vital Laboratories Private Limited.
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Colchicine Market, by Dosage Formulation
7. Colchicine Market, by Age
8. Colchicine Market, by Route of Administration
9. Colchicine Market, by Sales Channels
10. Colchicine Market, by Application
11. Americas Colchicine Market
12. Asia-Pacific Colchicine Market
13. Europe, Middle East & Africa Colchicine Market
14. Competitive Landscape
15. Competitive Portfolio
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Colchicine Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Colchicine Market?
3. What is the competitive strategic window for opportunities in the Colchicine Market?
4. What are the technology trends and regulatory frameworks in the Colchicine Market?
5. What is the market share of the leading vendors in the Colchicine Market?
6. What modes and strategic moves are considered suitable for entering the Colchicine Market?
Read More @ https://www.360iresearch.com/library/intelligence/colchicine?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Colchicine Market worth $2.49 billion by 2030, growing at a CAGR of 7.85% - Exclusive Report by 360iResearch here
News-ID: 3431034 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Colchicine
Colchicine API Market Revenue & Gross Margin, Opportunities, Challenges and Risk …
LOS ANGELES, United States: QY Research offers an encyclopedic study of the global Colchicine API market with holistic insights into vital factors and aspects that impact future market growth. The global Colchicine API market has been analyzed for the forecast period 2023-2029 and historical period 2015-2020. In order to help players to gain comprehensive understanding of the global Colchicine API market and its critical dynamics, the research study provides detailed qualitative…
Colchicine Market Size, Share, Growth Report 2030
Latest Updated Report 2023, The Global Colchicine Market to Growing A CAGR of % during forecast period of 2023-2030. The Market is segmented by Global Colchicine Market Breakdown by Application (AcuteGout, ChronicGout, OtherConditions) by Type (Tablet, OralSolution) and by Geography (North America, South America, Europe, Asia Pacific, MEA).
The Colchicine Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the…
Colchicine Market Report Revealing The Latest Trends And Advances From 2022 To 2 …
Colchicine Market report is the most suitable solution for the business requirements in many ways. The best tools have been adopted to generate this report which is SWOT analysis and Porter's Five Forces analysis. Nowadays, businesses are highly relying on the different segments covered in the market research report which presents better insights to drive the business into right direction. This market report is a complete overview of the market…
Colchicine Market Top Leading Players with Strategies and Forecast 2028
The global Colchicine market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Colchicine is a drug used to treat gout and is marketed under the brand names colcry, mitigare, zyclochin, and others. The FDA government has placed a ban on the drug Colchicine. Colchicine has been used as an anti-gout and anti-inflammatory medication for many years. Its purpose is to reduce the amount of uric…
Colchicine Market is expected to reach 1270 million US$ by 2025, QY Research
Colchicine is an alkaloid extracted from the bulb of colchicum. This medicine is used to treat acute attacks of gouty arthritis and prevent acute exacerbation of recurrent gouty arthritis.
Colchicine is a highly effective drug for the treatment of acute gout, but 50% to 80% of patients taking colchicine have had gastrointestinal side effects before the onset of gout, which has affected the growth of the colchicine market.
Colchicine has been FDA…
Global Colchicine Market 2017 - Indena, Sanmar Group, Alchem International, Alka …
Colchicine Market Research Report
A market study based on the " Colchicine Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Colchicine Market 2017’. The research report analyses the historical as well as present performance of the worldwide Colchicine industry, and makes predictions on the future status of Colchicine market on the basis of this analysis.
Request For Sample Copy of Report : http://bit.ly/2rKzu0T
Top…
